'%3e%3cpath%20d='M13.9089%2015.4039L2.36841%2031.3158H14.1058L19.7652%2023.4567L13.9089%2015.4039Z'%20fill='%23E30613'/%3e%3cpath%20d='M37.1054%2031.3158L25.5649%2015.4039L19.7654%2023.4567L25.4812%2031.3158H37.1054Z'%20fill='%23E30613'/%3e%3cpath%20d='M19.7367%207.36842L13.9088%2015.4038L19.7651%2023.4567L25.5646%2015.4038L19.7367%207.36842Z'%20fill='%23E30613'/%3e%3cpath%20d='M19.7367%207.36842L13.9088%2015.4038L19.7651%2023.4567L25.5646%2015.4038L19.7367%207.36842Z'%20fill='%23AE0F0A'/%3e%3cpath%20d='M25.481%2031.3158L19.7652%2023.4567L14.1057%2031.3158H25.481Z'%20fill='%23E4ADB5'/%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_55852_442'%3e%3crect%20width='40'%20height='40'%20fill='white'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e){kind=small}
'%3e%3cpath%20d='M103.486%2014L0%20158H105.251L156%2086.8766L103.486%2014Z'%20fill='%23AE0F0A'/%3e%3cpath%20d='M171%20-72L119%20-0.0779648L171.254%2072L223%20-0.0779648L171%20-72Z'%20fill='%23AE0F0A'/%3e%3cpath%20d='M370%20113L266.175%20-31L214%2041.8766L265.422%20113H370Z'%20fill='%23AE0F0A'/%3e%3cpath%20d='M257%20136L206.25%2066L156%20136H257Z'%20fill='%23DE1A0D'/%3e%3cpath%20d='M374.045%2065.8286L400.159%20-16.5947L313.999%20-15.3842L374.045%2065.8286Z'%20fill='%23DE1A0D'/%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_2008_21'%3e%3crect%20width='372'%20height='110'%20fill='white'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e)
'/%3e%3cpath%20d='M16.2857%200V1.425H40.7143V0V-1.425H16.2857V0ZM57%2016.2857H55.575V40.7143H57H58.425V16.2857H57ZM40.7143%2057V55.575H16.2857V57V58.425H40.7143V57ZM0%2040.7143H1.425V16.2857H0H-1.425V40.7143H0ZM16.2857%2057V55.575C8.07837%2055.575%201.425%2048.9216%201.425%2040.7143H0H-1.425C-1.425%2050.4956%206.50436%2058.425%2016.2857%2058.425V57ZM57%2040.7143H55.575C55.575%2048.9216%2048.9216%2055.575%2040.7143%2055.575V57V58.425C50.4956%2058.425%2058.425%2050.4956%2058.425%2040.7143H57ZM40.7143%200V1.425C48.9216%201.425%2055.575%208.07837%2055.575%2016.2857H57H58.425C58.425%206.50436%2050.4956%20-1.425%2040.7143%20-1.425V0ZM16.2857%200V-1.425C6.50436%20-1.425%20-1.425%206.50436%20-1.425%2016.2857H0H1.425C1.425%208.07837%208.07837%201.425%2016.2857%201.425V0Z'%20fill='%23F9F9F9'%20mask='url(%23path-1-inside-1_57102_13501)'/%3e%3cpath%20d='M46.7748%2038.5934L32.086%2013.0839C31.7189%2012.459%2031.1949%2011.9408%2030.5659%2011.5807C29.9368%2011.2207%2029.2246%2011.0312%2028.4998%2011.0312C27.7751%2011.0312%2027.0629%2011.2207%2026.4338%2011.5807C25.8048%2011.9408%2025.2808%2012.459%2024.9137%2013.0839L10.2248%2038.5934C9.87167%2039.1978%209.68555%2039.8854%209.68555%2040.5855C9.68555%2041.2856%209.87167%2041.9731%2010.2248%2042.5776C10.5871%2043.2064%2011.1102%2043.7276%2011.7404%2044.0874C12.3706%2044.4472%2013.0853%2044.6328%2013.811%2044.6251H43.1887C43.9138%2044.6322%2044.6278%2044.4463%2045.2574%2044.0865C45.887%2043.7267%2046.4095%2043.2059%2046.7715%2042.5776C47.1252%2041.9734%2047.3119%2041.286%2047.3125%2040.5859C47.3131%2039.8858%2047.1275%2039.1981%2046.7748%2038.5934ZM44.4451%2041.2321C44.3171%2041.4506%2044.1332%2041.631%2043.9124%2041.755C43.6917%2041.879%2043.4419%2041.942%2043.1887%2041.9376H13.811C13.5578%2041.942%2013.308%2041.879%2013.0873%2041.755C12.8665%2041.631%2012.6826%2041.4506%2012.5546%2041.2321C12.4386%2041.0358%2012.3774%2040.8119%2012.3774%2040.5838C12.3774%2040.3557%2012.4386%2040.1318%2012.5546%2039.9354L27.2434%2014.426C27.3741%2014.2086%2027.5588%2014.0287%2027.7795%2013.9038C28.0003%2013.7789%2028.2496%2013.7133%2028.5032%2013.7133C28.7568%2013.7133%2029.0062%2013.7789%2029.2269%2013.9038C29.4477%2014.0287%2029.6323%2014.2086%2029.763%2014.426L44.4518%2039.9354C44.5668%2040.1324%2044.6268%2040.3566%2044.6257%2040.5847C44.6245%2040.8128%2044.5621%2041.0364%2044.4451%2041.2321Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_57102_13501'%20x1='0'%20y1='0'%20x2='57'%20y2='57'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20offset='0.408654'%20stop-color='%23C2240C'/%3e%3cstop%20offset='1'%20stop-color='%23A10D03'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e)
[RÁDIO] Vacina Calixcoca, desenvolvida com apoio da Fapemig, vence Prêmio Euro
20/10/2023 15:45·Atualizado em 20/10/2023
Compartilhar no Facebook
Compartilhar no LinkedIn
Compartilhar no X
Compartilhar no WhatsApp
Copiar link
Cocaína e crack são os alvos do imunizante que já tem aval para início de testes em humanos. Ouça matéria de rádio.
A utilização deste conteúdo é livre e irrestrita.
Notícia Relacionada
Vacina Calixcoca, desenvolvida com apoio da Fapemig, vence Prêmio Euro